Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Actimed Therapeutics Ltd

Clinical trials sponsored by Actimed Therapeutics Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to stop muscle loss while shedding pounds Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug aims to stop muscle loss while shedding pounds

Disease control Recruiting now

This study tests whether a drug called ACM-001.1 can help obese people keep their muscle while taking semaglutide for weight loss, and help them regain muscle after stopping semaglutide. About 120 participants will receive either ACM-001.1 or a placebo alongside semaglutide, and …

Phase 2 • Sponsor: Actimed Therapeutics Ltd • Aim: Disease control

Last updated Jun 27, 2026 09:06 UTC